A patient diagnosed by a doctor after percutaneous pedicle screw internal fixation for a compression fracture of the thoracolumbar vertebra/Patients who underwent unilateral total knee arthroplasty for the first time due to knee osteoarthritis
Conditions
Interventions
Non exposure group (On the basis of perioperative management of accelerated rehabilitation surgery, compound pain capsule was not used for treatment):NA
Sponsors
The Third Affiliated Hospital of Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Target population 1: 1.Patients diagnosed by doctors after percutaneous pedicle screw internal fixation for thoracolumbar compression fractures; 2.Acceptance of ERAS management measures; Target population 2: 1.Patients who underwent unilateral total knee arthroplasty for the first time due to knee osteoarthritis; 2. Acceptance of ERAS management measures;
Exclusion criteria
Exclusion criteria: Target population 1: 1.Patients with preoperative spinal nerve injury; 2.Weak stool in the spleen and stomach or chronic diarrhea; 3.Patients who need surgery due to bone tumors; 4.Patients with brain, chest and abdomen internal organ injury and osteofascial compartment syndrome; 5.Patients with heart failure, filariasis, renal insufficiency, etc. that can lead to limb/local swelling before admission; 6.There are coagulation function, mental dysfunction; 7.People who are allergic to investigational drugs; 8.Patients who are currently participating in other clinical studies; 9. The researcher thinks that it is not appropriate to join the researcher; Target population 2: 1.Weak stool in the spleen and stomach or long-term chronic diarrhea; 2.Patients who need surgery due to bone tumors; 3.Patients with brain, chest and abdomen internal organ injury and osteofascial compartment syndrome; 4.Patients with related diseases such as heart failure, filariasis, renal insufficiency, etc. that can lead to limb/local swelling before admission; 5.Patients with coagulation function and mental dysfunction; 6.Allergic to investigational drugs; 7.Patients who are currently participating in other clinical studies; 8. The researcher thinks that it is not appropriate to participate in this researcher;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative pain VAS score decreased to 3 points;Time of first postoperative defecation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time of first postoperative anal exhaust;Postoperative pain VAS scores of all viewpoints;Postoperative low back pain dysfunction index;European five-dimensional Health Scale;Incidence of postoperative deep venous thrombosis of lower extremity;hospital stays;Unplanned readmission rate within 31 days after discharge;Postoperative months pain-free days;Postoperative lower limb swelling;Postoperative use of analgesics; | — |
Countries
China
Contacts
Public ContactWeiheng Chen
The Third Affiliated Hospital of Beijing University of Chinese Medicine
Outcome results
None listed